By Josh White
Date: Tuesday 27 Feb 2024
(Sharecast News) - Life science company SkinBioTherapeutics reported encouraging interim findings from its ongoing AxisBiotix acne food supplement study featuring its lead formulation on Tuesday.
By Josh White
Date: Friday 26 Jan 2024
(Sharecast News) - SkinBioTherapeutics announced on Friday that it has finalised the acquisition of Dermatonics, known for its topical and dermatological products within the skincare and wound care sector.
By Iain Gilbert
Date: Wednesday 25 Oct 2023
(Sharecast News) - Life sciences company SkinBioTherapeutics said on Wednesday that it had begun a new consumer study into acne, with two new formulas set to be trialled in order to compare efficacy against "the most common skin condition".
Currency | UK Pounds |
Share Price | 9.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 29.00 |
52 Week Low | 7.25 |
Volume | 122,323 |
Shares Issued | 202.26m |
Market Cap | £18.71m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:27 | 17,500 @ 9.36p |
15:30 | 20,000 @ 9.13p |
15:30 | 20,000 @ 9.00p |
13:58 | 5,613 @ 9.37p |
13:02 | 10,630 @ 9.36p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research